Navigation Links
Horizons AMI trial data to be presented at TCT 2007
Date:10/15/2007

WASHINGTON, DC OCTOBER 15, 2007 -- The Cardiovascular Research Foundation (CRF) will release results of its landmark research study, HORIZONS AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) at the nineteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C. The study is designed to examine the safety and effectiveness of stents and anticoagulants in heart attack patients undergoing angioplasty.

The HORIZONS AMI trial data will be presented at a press conference on Wednesday, October 24 at 8:40 am. The results will be presented as a late breaking trial on Wednesday, October 24 at 10:50 am.

This is a landmark trial, which will help set guidelines for drug and stent therapy during primary angioplasty in patients with heart attacks for many years to come, said Gregg W. Stone, MD, Chairman of the Cardiovascular Research Foundation and Professor of Medicine, Columbia University Medical Center.

While previous studies of drug-eluting stents have often focused on their use in patients with stable or unstable chest pain, this is the largest study to focus on the appropriate use of anticoagulation medications and drug-eluting stents in patients experiencing the highest risk form of heart attack (ST-elevation myocardial infarction).

Usually, angioplasty is associated with an excess of bleeding in heart attack patients, Dr. Stone said. However, using the anticoagulant bivalirudin with angioplasty in patients with stable coronary artery disease instead of heparin and glycoprotein IIb/IIIa inhibitors reduces bleeding, which has been associated with greater long-term survival. In the HORIZONS AMI trial, we have sought to determine whether using bivalirudin in patients with a heart attack, who undergo angioplasty, provides the same benefit.

This study should determine if bivalirudin use is as efficacious as the standard anticoagulant therap
'/>"/>

Contact: Irma Damhuis
idamhuis@crf.org
212-851-9187
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Man against HIV – new vaccine ready for human trials
2. FDA approves Phase 0 trial which tests experimental drugs on humans
3. Male contraceptive in trial
4. How do patients benefit of clinical trials
5. Glenmark’s new molecule to go through trial
6. Clinical trials need to be more frank
7. First head-to-head trials of once weekly Fosamax and Actonel therapies
8. Hormone Replacement Therapy increases the risk of endometrial cancer
9. Atrial fibrillation predicts for acute ischaemic stroke
10. Spray on contraceptive clears Phase I trial
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Medical education in sub-Saharan Africa is being revitalized ... dramatically increasing enrollment, broadening curricula, upgrading Internet access ... , In the first substantial publication by ... Initiative (MEPI), more than 225 authors detailed progress ... are in a supplement being published today by ...
(Date:7/30/2014)... Steven Reinberg HealthDay Reporter ... in the United States, at least 2,000 Americans die from ... Wednesday. Heat waves, heat stroke or sun stroke caused ... 2006 and 2010, according to the U.S. Centers for Disease ... severe loss of body heat -- accounted for 63 percent ...
(Date:7/30/2014)... Hayward, CA (PRWEB) July 30, 2014 ... and accessories at the lowest prices on the internet ... Lightning Cables in two lengths and two colors. These ... performance standards. , The high quality SF Cable ... 8-pin connector with digital signal delivering faster charging and ...
(Date:7/30/2014)... Hawley, Pennsylvania (PRWEB) July 30, 2014 ... and have contributed over $8,500 to ensure its protection. ... Resort, presents a check to the Delaware Highlands Conservancy ... Partnership program. The small $2-per-stay donations add up fast, ... future of the Upper Delaware River Region. , The ...
(Date:7/30/2014)... 30, 2014 DRE Medical — a ... the launch of its Medical Trade Shows & ... medical professionals and equipment vendors. , The calendar is ... in the United States and around the world. Hundreds ... that number is always growing. , Information listed on ...
Breaking Medicine News(10 mins):Health News:Journal supplement details progress in African medical education 2Health News:Journal supplement details progress in African medical education 3Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 3Health News:SF Cable Delivers Certified Lightning Cable in Multiple Sizes and Colors 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:DRE Launches Online Interactive Medical Trade Show Calendar 2
... TUESDAY, June 21 (HealthDay News) -- Because policies that ... well-being, the potential health effects of major legislation or ... government, says an Institute of Medicine report released Tuesday. ... legislation to meet current challenges, such as the obesity ...
... being married boosts survival odds for both men and women ... Married patients had a 14 percent lower risk of death ... Brigham Young University. That estimate is based on analysis of ... of cancers, the researchers did find that married people were ...
... HealthDay Reporter , MONDAY, June 20 (HealthDay News) ... meant to lower blood pressure requires multiple readings, new ... appointments, a condition known as "white coat" hypertension, so ... said the study,s lead author, Dr. Benjamin Powers, assistant ...
... This release is available in Spanish . ... a powerful effect on formation of strong, healthy bones, if ... true for humans. Jin-Ran Chen and his colleagues ... Department of Agriculture (USDA) at the Arkansas Children,s Nutrition Center ...
... 2011)In a study that increases the understanding of the ... researchers at Los Angeles Biomedical Research Institute at Harbor-UCLA ... two common hormones, insulin and leptin, in utero changes ... that regulates appetite. Their study using fetal neural ...
... HealthDay Reporter , MONDAY, June 20 (HealthDay News) ... A beat the anti-wrinkle medication Botox in a trial that ... lines of aging around the eyes known as "crow,s feet." ... patients picked Dysport over the Botox in terms of wrinkle ...
Cached Medicine News:Health News:Lawmakers Urged to Consider Health Effects of Major Legislation 2Health News:Single Reading Can't Gauge Blood Pressure Control: Study 2Health News:Single Reading Can't Gauge Blood Pressure Control: Study 3Health News:Blueberries help lab rats build strong bones 2Health News:LA BioMed study increases understanding of link between low birth weights and obesity later in life 2Health News:Study Finds Botox Alternative Better at Smoothing 'Crow's Feet' 2Health News:Study Finds Botox Alternative Better at Smoothing 'Crow's Feet' 3Health News:Study Finds Botox Alternative Better at Smoothing 'Crow's Feet' 4
(Date:7/30/2014)... 2014  Hologic, Inc. (NASDAQ: HOLX ) ... ended June 28, 2014. Third Quarter Financial ... to $632.6 million, reflecting operational growth of 0.5% and ... same period in the prior year. , Revenues ... Breast Health revenues grew 3.5%. , GYN Surgical ...
(Date:7/30/2014)... CUPERTINO, Calif. , July 30, 2014 ... ) second quarter 2014 financial results press release, you ... will be broadcast live over the internet on Thursday, ... pm Pacific Time). A live audio webcast ... homepage at http://www.durect.com and clicking "Investor Relations."  ...
(Date:7/30/2014)... PuraMed BioScience ® , Inc., (OTCPink:PMBS), ... medicinal and healthcare products, announced today that the ... with the name,s red and yellow logo. The ... MigraPure ®  going forward. The new name, ... migraine pain reliever will be reintroduced into selected ...
Breaking Medicine Technology:Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3
... Jan. 11, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... the Company to address the dual epidemics of diabetes and ... the year and place the Company on the path to ... presented by Daniel M. Bradbury, president and chief executive officer, ...
... 11 Spherix Inc. (Nasdaq: SPEX ), an innovator ... and regulatory consulting services to food, supplement, biotechnology and pharmaceutical ... be presenting at the Annual OneMedPlace Finance Forum, which is ... Francisco, CA. Dr. Lodder will deliver the Company,s corporate ...
Cached Medicine Technology:Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference 2Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference 3Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco 2Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco 3
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: